ERYP — Stock activity · TradeandTell
ERYP ERYP $0.78 +$0.00 (+0.00%) prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
Financials Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
Income Balance sheet Cash flow
2015 2016 2017 2018 2019 2020 2021 2022 $10.8M $19.7M $3.4M $4.1M $3.4M $0 $0 $0 $10.8M $19.7M $25.5M $33.5M $52.2M $57.6M $0 $0 $0 $0 −$22.1M −$29.3M −$48.8M −$57.6M $0 $0 0.0% 0.0% -656.9% -708.8% -1451.5% — — — $0 $0 $25.5M −$19.7M $52.2M $57.6M $45.1M $19.9M −$15.6M −$22.4M −$30.9M $4.4M $5.3M −$68.8M −$56.5M −$2.8M −$14.7M −$21.5M $3.4M $4.4M $11.2M −$67.1M −$46.3M $4.6M −$15.0M −$21.9M −$33.5M −$38.2M −$62.7M −$73.3M −$53.8M −$228.0K -139.3% -111.1% -996.7% -923.7% -1862.6% — — — -2.16 -2.74 -1.87 -2.13 -3.49 -3.99 -2.27 -0.01
Annual figures · source: Financial Modeling Prep
Peer comparison Symbol Price Today Mkt cap P/E ERYP ERYTECH Pharma S.A. $0.78 +1.30% $47M — ALVR AlloVir, Inc. $9.81 +4.14% $49M — BLUE bluebird bio, Inc. $4.97 +0.00% $49M — CERC Cerecor Inc. $2.93 -1.68% $39M — GRNA GreenLight Biosciences Holdings $0.30 -0.03%
Held by traders on TradeandTell No one on the platform currently holds ERYP.
Super investors & insiders Institutions holding (13F)
No tracked institution reports a position in ERYP as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell No one on the platform has traded ERYP yet.
Report a bug KRON Kronos Bio, Inc. $0.88 +1.49% $54M —
MGTA Magenta Therapeutics, Inc. $0.70 -7.74% $42M —
Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$ERYP chatter on StockTwits ERYTECH Pharma S.A. Files SEC Form 6-K $ERYP https://www.marketbeat.com/stocks/NASDAQ/ERYP/sec-filings/
View on StockTwits ↗ $ERYP shows quite a strong growth in Revenue. Over the last 5 years, it has been growing by 14.60% yearly. https://www.chartmill.com/stock/quote/ERYP/fundamental-analysis?key=c4b723d5-e7e0-4eb6-b924-0dc48f032dd5&utm_source=stocktwits&utm_medium=FA&utm_content=ERYP&utm_campaign=social_tracking
View on StockTwits ↗ ERYTECH Pharma S.A. Files SEC Form 6-K $ERYP https://www.marketbeat.com/stocks/NASDAQ/ERYP/sec-filings/
View on StockTwits ↗ $ERYP [15s. delayed] filed form 6-K on June 30, 11:33:12 https://s.flashalert.me/rck9F
View on StockTwits ↗ ERYTECH Pharma Sees Short Interest Decrease from 37,900 shares to 17,800 shares. $ERYP https://www.marketbeat.com/stocks/NASDAQ/ERYP/short-
View on StockTwits ↗ $ERYP [15s. delayed] filed form 424B3 on June 29, 15:52:47 https://s.flashalert.me/KJoFu
View on StockTwits ↗ ERYTECH Pharma S.A. Files SEC Form 6-K $ERYP https://www.marketbeat.com/stocks/NASDAQ/ERYP/sec-filings/
View on StockTwits ↗ $ERYP [15s. delayed] filed form 6-K on June 28, 08:53:59 https://s.flashalert.me/FS3yNl
View on StockTwits ↗ $ERYP - Erytech Pharma max pain price is slumping https://www.macroaxis.com/stock-options/ERYP/Erytech-Pharma-SA?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗ $ERYP [15s. delayed, acc.~90%, always check] Earnings Release June 23, 16:30:00: https://s.flashalert.me/j0ql8
View on StockTwits ↗ $ERYP [15s. delayed]: Issued Press Release on June 23, 16:30:00: ERYTECH announces the approval of the merger with Pherecydes and reports https://s.flashalert.me/HLxoQX
View on StockTwits ↗ ERYTECH Pharma S.A. Files SEC Form 6-K $ERYP https://www.marketbeat.com/stocks/NASDAQ/ERYP/sec-filings/
View on StockTwits ↗ Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
